Low adherence to bisphosphonate therapy is associated with increased fracture risk. Since factors associated with discontinuation of osteoporosis medications have not been studied in-depth, Dr. Huifeng Yun, assistant professor in the department of epidemiology at the University of Alabama at Birmingham, assessed medication discontinuation and switching patterns among Medicare beneficiaries who were new users of bisphosphonates and evaluated factors possibly associated with discontinuation.